UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy

Journal of clinical oncology, 1995-11, Vol.13 (11), p.2737-2744

1995

Volltextzugriff (PDF)

A Prospective Pharmacologic Evaluation of Age-Related Toxicity of Adjuvant Chemotherapy in Women with Breast Cancer

Cancer investigation, 2000, Vol.18 (6), p.521-529

2000

Volltextzugriff (PDF)

Factors affecting treatment decisions for a life-threatening illness: The case of medical treatment of breast cancer

Social science & medicine (1982), 1991, Vol.32 (7), p.813-818

1991

Volltextzugriff (PDF)

Doctor-patient communication about breast cancer adjuvant therapy

Journal of clinical oncology, 1989-09, Vol.7 (9), p.1192-1200

1989

Volltextzugriff (PDF)

Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study

Journal of clinical oncology, 1998-07, Vol.16 (7), p.2382-2391

1998

Volltextzugriff (PDF)

Use of hematopoietic colony-stimulating factors : The American society of clinical oncology survey

Journal of clinical oncology, 1996-09, Vol.14 (9), p.2511-2520

1996

Volltextzugriff (PDF)

Effects of outcome framing on treatment decisions in the real world: impact of framing on adjuvant breast cancer decisions

Medical decision making, 1989-10, Vol.9 (4), p.262-271

1989

Volltextzugriff (PDF)

Quality-of-Life Assessment in Cancer Clinical Trials: A Status Report

JNCI : Journal of the National Cancer Institute, 1992-07, Vol.84 (13), p.994-995

1992

Volltextzugriff (PDF)

Long term follow‐up of women treated with 16‐week, dose‐intensive adjuvant chemotherapy for high risk breast carcinoma

Cancer, 1999-02, Vol.85 (4), p.899-904

1999

Volltextzugriff (PDF)

Evaluating quality and quantity of life in breast cancer adjuvant trials

Journal of clinical oncology, 1988-12, Vol.6 (12), p.1795-1797

Fetting, J H

1988

Volltextzugriff (PDF)

Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study

Journal of clinical oncology, 1990-09, Vol.8 (9), p.1476-1482

1990

Volltextzugriff (PDF)

A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer

Cancer chemotherapy and pharmacology, 1999, Vol.43 (6), p.497-502

1999

Volltextzugriff (PDF)

Sixteen-Week Dose-Intense Chemotherapy in the Adjuvant Treatment of Breast Cancer

JNCI : Journal of the National Cancer Institute, 1990-04, Vol.82 (7), p.570-574

1990

Volltextzugriff (PDF)

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

Breast cancer research and treatment, 2018-08, Vol.171 (1), p.121-129

2018

Volltextzugriff (PDF)

Noradrenergic activity in anticipatory nausea

Psychosomatic medicine, 1992-11, Vol.54 (6), p.641-647

1992

Volltextzugriff (PDF)

The Effect of Aging on the Utilization of Chemotherapy for Metastatic Breast Cancer: A Population-Based Study

Cancer investigation, 1997, Vol.15 (3), p.199-203

1997

Volltextzugriff (PDF)

Cognitive Assessment of Cancer Patients

Cancer, 1984-05, Vol.53 (10 Suppl), p.2250-2255

1984

Volltextzugriff (PDF)

A comparison of the symptoms of medical and psychiatric patients matched on the Beck Depression Inventory

General hospital psychiatry, 1987-11, Vol.9 (6), p.398-404

1987

Volltextzugriff (PDF)

Triple-negative breast cancer (TNBC) outcomes with partial breast irradiation and concurrent chemotherapy (PBI-CC) compared with whole breast irradiation and sequential chemotherapy (WBI-SC)

Journal of clinical oncology, 2011-09, Vol.29 (27_suppl), p.115-115

2011

Volltextzugriff (PDF)

A phase II pharmacokinetic/pharmacogenetic (PK/PG) study using fixed-dose capecitabine in metastatic breast cancer (MBC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.1067-1067

2011

Volltextzugriff (PDF)

A multi-institutional double-blind phase II study evaluating response and surrogate biomarkers to carboplatin and nab-paclitaxel (CP) with or without vorinostat as preoperative systemic therapy (PST) in HER2-negative primary operable breast cancer (TBCRC008)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.TPS111-TPS111

2010

Volltextzugriff (PDF)

Anticipatory nausea and vomiting: Does it remain a significant clinical problem?

Cancer, 1988-12, Vol.62 (12), p.2654-2657

1988

Volltextzugriff (PDF)

Psychosocial and other supportive aspects of breast cancer care

Current opinion in oncology, 1989-12, Vol.1 (2), p.333-336

Fetting, J H

1989

Volltextzugriff (PDF)

Increasing doses of cyclophosphamide suppress antigen-specific T helper-dependent immunity induced by a GM-CSF-secreting breast tumor vaccine

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.3009-3009

2008

Volltextzugriff (PDF)

Pathologic complete response (pCR) to preoperative sequential doxorubicin/cyclophosphamide (AC) and taxane (AC-T) or AC followed by paclitaxel and trastuzumab (AC-TH) in stage II-III HER2-positive breast cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.11521-11521

2008

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(74)
magazinearticle
(1)

Sprache

Englisch
(72)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(51)
Science & Technology
(47)
Life Sciences & Biomedicine
(45)
Female
(40)
Oncology
(36)
Middle Aged
(33)
Adult
(30)
Biological And Medical Sciences
(28)
Medical Sciences
(25)
Breast Neoplasms - Drug Therapy
(24)
Aged
(21)
Pharmacology. Drug Treatments
(16)
Antineoplastic Agents
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Breast Cancer
(12)
Chemotherapy
(12)
Quality Of Life
(12)
Cyclophosphamide - Administration & Dosage
(11)
Breast Neoplasms - Psychology
(10)
Doxorubicin - Administration & Dosage
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy

A Prospective Pharmacologic Evaluation of Age-Related Toxicity of Adjuvant Chemotherapy in Women with Breast Cancer

Factors affecting treatment decisions for a life-threatening illness: The case of medical treatment of breast cancer

Doctor-patient communication about breast cancer adjuvant therapy

Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study

Use of hematopoietic colony-stimulating factors : The American society of clinical oncology survey

Effects of outcome framing on treatment decisions in the real world: impact of framing on adjuvant breast cancer decisions

Quality-of-Life Assessment in Cancer Clinical Trials: A Status Report

Long term follow‐up of women treated with 16‐week, dose‐intensive adjuvant chemotherapy for high risk breast carcinoma

Evaluating quality and quantity of life in breast cancer adjuvant trials

Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study

A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer

Sixteen-Week Dose-Intense Chemotherapy in the Adjuvant Treatment of Breast Cancer

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

Noradrenergic activity in anticipatory nausea

The Effect of Aging on the Utilization of Chemotherapy for Metastatic Breast Cancer: A Population-Based Study

Cognitive Assessment of Cancer Patients

A comparison of the symptoms of medical and psychiatric patients matched on the Beck Depression Inventory

Triple-negative breast cancer (TNBC) outcomes with partial breast irradiation and concurrent chemotherapy (PBI-CC) compared with whole breast irradiation and sequential chemotherapy (WBI-SC)

A phase II pharmacokinetic/pharmacogenetic (PK/PG) study using fixed-dose capecitabine in metastatic breast cancer (MBC)

A multi-institutional double-blind phase II study evaluating response and surrogate biomarkers to carboplatin and nab-paclitaxel (CP) with or without vorinostat as preoperative systemic therapy (PST) in HER2-negative primary operable breast cancer (TBCRC008)

Anticipatory nausea and vomiting: Does it remain a significant clinical problem?

Psychosocial and other supportive aspects of breast cancer care

Increasing doses of cyclophosphamide suppress antigen-specific T helper-dependent immunity induced by a GM-CSF-secreting breast tumor vaccine

Pathologic complete response (pCR) to preoperative sequential doxorubicin/cyclophosphamide (AC) and taxane (AC-T) or AC followed by paclitaxel and trastuzumab (AC-TH) in stage II-III HER2-positive breast cancer

Suchergebnisse filtern